Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

STAA

+ Watchlist+ Portfolio

STAAR Surgical Company

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$25.56
52-Week Range
$15.59 – $35.87
Market Cap
$1.27B
P/E (TTM)
2535.00
EPS (TTM)
0.01
Dividend Yield
0.00%
Advanced Metrics
Price/Book
3.38
PEG Ratio
0.76
Return on Equity
0.14%
Return on Assets
2.96%
Gross Margin
73.56%
Operating Margin
6.79%
Profit Margin
0.16%
Current Ratio
4.68
Debt/Equity
0.09
Total Debt
$33.64M
Free Cash Flow
$41.75M
Revenue Growth
-12.00%
Earnings Growth
-38.50%
Enterprise Value
$1.10B

Market Snapshot

About

STAAR Surgical Company designs, develops, and manufactures implantable lenses for the eye. The company specializes in the EVO Implantable Collamer Lens for vision correction, offering an alternative to LASIK for patients with moderate to severe myopia.